Clinical Trial Update: Inhaled and Intravenous Milrinone in Patients With Severe Pulmonary Hypertension [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating inhaled and intravenous milrinone in patients with severe pulmonary hypertension due to left heart disease and is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension Due to Left Heart Disease

Drugs mentioned

• Milrinone (milrinone)

Snippet

Sponsor: Zagazig University | Conditions: Pulmonary Hypertension Due to Left Heart Disease | Phase 4 | Status: RECRUITING